AVTX Market Cap & Key Metrics
Avalo Therapeutics, Inc.
$12.15
+$0.31(+2.62%)
32
Overall
60
Value
9
Tech
28
Quality
Market Cap
$634.98M
Volume
261.81K
52W Range
$12.51 - $24.27
Target Price
$44.08
AVTX market cap is $634.98M. This page lists Avalo Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
AVTX Key Metrics
- Market cap
- $634.98M
- EPS estimate, current year
- $-2.80
- EPS growth, 3-year
- +82.36%
- Value score
- 60
- Quality score
- 28
- Technical score
- 9
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $59.0K | $441.0K | $1.92M | $18.05M | $5.40M |
| EBITDA | -$82.10M | -$38.16M | -$27.95M | -$35.91M | -$80.50M |
| EPS | $-5.84 | $-7.94 | $-114.00 | $-1063.20 | $-14342.40 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVTX | $12.15 | +2.6% | 261.81K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Avalo Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW